Toll-like receptor 2 and 4 response and expression on monocytes decrease rapidly in patients undergoing arterial surgery and are related to preoperative smoking

Shock

Volumn 31, Issue 1, 2009, Pages 21-27

  Versteeg, Dik ^a   Dol, Erik ^a   Hoefer, Imo E ^a   Flier, Suzanne ^b   Buhre, Wolfgang F ^b   De Kleijn, Dominique ^a,c   Van Dongen, Eric P ^d   Pasterkamp, Gerard ^a,b   De Vries, Jean Paul ^e  

^a Experimental Cardiology Laboratory   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^d Departments of Anesthesiology   (Netherlands)

^e ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Arterial injury; Smoking; Surgery; TNF ; Tolerance; Toll like receptor

Indexed keywords

LIGAND; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTERY INJURY; ARTERY SURGERY; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; INTRAOPERATIVE PERIOD; MALE; MONOCYTE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTEIN EXPRESSION; SMOKING; STIMULATION; SUPERNATANT; SURGICAL INJURY; SURGICAL PATIENT; VASCULAR SURGERY;

AGED; ARTERIES; CYSTEINE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MALE; MIDDLE AGED; MONOCYTES; SMOKING; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR SURGICAL PROCEDURES;

EID: 58849162767     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31817d43bf     Document Type: Article

References (47)

1. Hiki N, Mimura Y. Hatao F, Kojima J. Ogawa T, Tsuji E. Kaminishi M: Sublethal endotoxin administration evokes super-resistance to systemic hypoxia in rats. J Trauma 54:584-589. 2003.
2. Versteeg D. Hoefer I, Schoneveld A, de Kleijn D, Busser E. Strijder C. Emons M. Stella P. Doevendans P. Pasterkamp G: Monocyte Toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve. Heart 94:770-776. 2008.
3. Medzhitov R. Janeway C Jr: The toll receptor family and microbial recognition. Trends Microbiol 8:452-456. 2000.
4. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135-145. 2001.
5. O'Neill LA. Greene C: Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 63:650-657, 1998.
6. Beutler B: Inferences, questions and possibilities in toll-like receptor signalling. Nature 430:257-263, 2004.
7. Bareness KA, Arcaroli J, Harken AH, Abraham E, Banerjee A, Reznikov L. Mclntyre RC: Hemorrhage-induced acute lung injury is TLR4 dependent. Am J Physiol Regul Integr Comp Physiol 287:R592-R599, 2004.
8. Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA, Bourcier T: Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice. Circulation 109:784-789. 2004.
9. Wolfs TG, Buurman WA. van Schadewijk A, de Vries B. Daemen MA. Hiemstra PS, van't V: In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168:1286-1293. 2002.
10. Tsung A. Sahai R, Tanaka H. Nakao A. Fink MP. Lotze MT, Yang H. Li J. Tracey KJ, Geller DA, et al.: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201:1135 1143. 2005.
11. Fondevila C. Busuttil RW, Kupiec-Weglinski JW: Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol 74:86-93. 2003.
12. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999.
13. Hansson GK. Libby P: The immune response in atherosclerosis: a doubleedged sword. Nat Rev Immunol 6:508-519. 2006.
14. Michelsen KS. Doherty TM, Shah PK. Arditi M: Role of toll-like receptors in atherosclerosis. Circ Res 95:e96-e97. 2004.
15. Vink A, de Kleijn DP, Pasterkamp G: Functional role for toll-like receptors in atherosclerosis and arterial remodeling. Curr Opin Lipidol 15:515-521. 2004.
16. Vink A, Schoneveld AH, van der Meer JJ, Van Middelaar BJ. Sluijter JP. Smeets MB. Quax PH. Lim SK, Borst C, Pasterkamp G, et al.: In vivo evidence for a role of Toll-like receptor 4 in the development of intimal lesions. Circulation 106:1985-1990. 2002.
17. Hollestelle SC, De Vries MR, Van Keulen JK. Schoneveld AH. Vink A. Strijder CF. Van Middelaar BJ. Pasterkamp G. Quax PH. de Kleijn DP: Tolllike receptor 4 is involved in outward arterial remodeling. Circulation 109: 393-398, 2004.
18. Mullick AE. Tobias PS. Curtiss LK: Modulation of atherosclerosis in mice by toll-like receptor 2. J Clin Invest 115:3149-3156. 2005.
19. Schoneveld AH. Oude Nijhuis MM. van Middelaar B. Laman JD, de Kleijn DP. Pasterkamp G: Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Cardiovasc Res 66:162-169. 2005.
20. Granowitz EV. Porat R, Mier JW. Orencole SF, Kaplanski G. Lynch EA. Ye K. Vannier E, Wolff SM, Dinarello CA: Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 151:1637-1645, 1993.
21. Munoz C, Carlet J, Fitting C, Missel B. Bleriol JP. Cavaillon JM: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747-1754, 1991.
22. Gonnella PA, Starr S, Rodrick ML. Wilmore DW: Induced hyporesponsiveness in rat Kupffer cells is not specific for lipopolysaccharide. Immunology 81:402-406, 1994.
23. Munford RS, Pugin J: Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163:316-321, 2001.
24. Lendemans S, Peszko A. Oberbeck R, Schmitzl D, Husain B, Burkhard M. Schade FU. Flohe S: Microcircuiatory alterations of hepatic and mesenteric microcirculation in endotoxin tolerance. Shock 29:223-231. 2008.
25. Faist E, Schinkel C. Zimmer S: Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 20:454-459. 1996.
26. Wheeler DS, Lahni PM. Denenberg AG, Poynter SE. Wong HR. Cook JA. Zingarelli B: Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock 30:267-273. 2008.
27. West MA, Clair L. Kraatz J, Rodriguez JL: Endotoxin tolerance from lipopolysaccharide pretreatment induces nuclear factor-kappab alterations not present in c3h/hej mice. J Trauma 49:298-305, 2000.
28. Kawasaki T. Ogata M. Kawasaki C. Tomihisa T, Okamoto K, Shigematsu A: Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery. Anesth Analg 92:1322-1326, 2001.
29. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, Miyake K, Takeda K, et al.: Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface tolllike receptor 4 expression. J Immunol 164:3476-3479, 2000.
30. Cavaillon JM: The nonspecific nature of endotoxin tolerance. Trends Microbiol 3:320-324, 1995.
31. Kariko K, Weissman D, Welsh FA: Inhibition of Toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 24:1288-1304, 2004.
32. Kilmartin B. Reen DJ: HSP60 induces self-tolerance to repeated HSP60 stimulation and cross-tolerance to other pro-inflammatory stimuli. Eur J Immunol 34:2041-2051, 2004.
33. Kuntscher MV, Hartmann B, Germann G: Remote ischemic preconditioning of flaps:a review. Microsurgery 25:346-352, 2005.
34. Gidday JM: Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7:437-448, 2006.
35. Hausenloy DJ, Yellon DM: Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70:240-253, 2006.
36. Schoneveld AH, Hoefer I, Sluijter JP, Laman JD, de Kleijn DP, Pasterkamp G: Atherosclerotic lesion development and toll like receptor 2 and 4 responsiveness. Atherosclerosis 197:95-104, 2008.
37. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, Billiar TR: Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26:430-437, 2006.
38. Lemaire LC, van der Poll T, van Lanschot JJ, Endert E, Buurman WA, van Deventer SJ, Gouma DJ: Minimally invasive surgery induces endotoxin-tolerance in the absence of detectable endotoxemia. J Clin Immunol 18:414-420, 1998.
39. Tracey KJ: The inflammatory reflex. Nature 420:853-859, 2002.
40. van Westerloo DJ, Weijer S, Bruno MJ, de Vos AF, Van't Veer C, van der Poll T: Toll-like receptor 4 deficiency and acute pancreatitis act similarly in reducing host defense during murine Escherichia coli peritonitis. Crit Care Med 33:1036-1043, 2005.
41. van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, Tracey KJ, van der Poll T: The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130:1822-1830, 2006.
42. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM, et al.: Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nut Immunol 6:844-851, 2005.
43. Giebelen IA, van Westerloo DJ, Larosa GJ, de Vos AF, van der Poll T: Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 28:700-703, 2007.
44. Ulloa L: The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 4:673-684, 2005.
45. Sebastian A, Pehrson C, Larsson L: Elevated concentrations of endotoxin in indoor air due to cigarette smoking.J Environ Monit 8:519-522, 2006.
46. Heagy W, Nieman K, Hansen C, Cohen M, Danielson D, West MA: Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients. Surg Infect (Larchmt) 4:171-180, 2003.
47. Ploder M, Pelinka L, Schmuckenschlager C, Wessner B, Ankersmit HJ, Fuerst W, Redl H, Roth E, Spittler A: Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-dr expression is correlated with survival in septic trauma patients. Shock 25:129-134. 2006.